Akums Drugs and Pharmaceuticals unveils nasal sprays, ET HealthWorld


New Delhi: Akums Drugs and Pharmaceuticals announces foray into nasal sprays. Its globally well-accepted dosage form provides convenience of administration, improved patient compliance and quicker onset of action and finds their usage across multiple therapies including respiratory, neurology, analgesics among others which can be used for local as well as systemic action.

Sanjeev Jain, Jt. MD of Akums Drugs and Pharmaceuticals, said, “We believe that the enthusiasm for advancing healthcare serves as a driving force, pushing us to continuously explore new avenues of innovation and challenge the limits of nasal spray development.”

The pharmaceutical industry is witnessing significant growth and innovations in the manufacturing of nasal spray products, creating opportunities in the market for which the demand for nasal spray products is not limited to developed countries but also surging in developing countries, such as China, Brazil, and India.

In addition to addressing common respiratory conditions, nasal sprays hold promise for broader medical applications, exploring new possibilities, making nasal spray a fast and effective means of delivering medications.

Sandeep Jain, Jt. MD of Akums Drugs and Pharmaceuticals, emphasizes the role of the company in meeting the growing demand, stating, “The increasing number of product launches and approvals for generic nasal spray products further propel the market growth.”

  • Published On Feb 6, 2024 at 05:37 PM IST

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles

Scan to download App


Leave a Reply

Your email address will not be published. Required fields are marked *